Hans Hull, Chief Business Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 54,969 shares at $20.01 ($1.1M) on 2023-08-04, disclosed to the SEC on 2023-08-07.
Scheduled sale ($1.1M) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 1,800 | $36K | 3.3% |
| 2 | $20.00 | 13,069 | $261K | 23.8% |
| 3 | $20.01 | 20,050 | $401K | 36.5% |
| 4 | $20.01 | 20,050 | $401K | 36.5% |
| Total | $20.01 avg | 54,969 | $1.1M | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $646K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $479K | — | Filing → |